Oncology Residency

The Department of Pharmacy at Harris Health System offers a one-year PGY2 Oncology Pharmacy Residency Program. Our PGY2 Oncology residency program builds on the Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized Hematology / Oncology areas of practice.

PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete our PGY2 oncology residency are well prepared to provide advanced Hematology / Oncology patient care in both acute and ambulatory oncology care settings, academia, or other specialized positions, along with board certification opportunity.

ASHP Logo Candidate

Candidate for PGY2 Oncology Program

Residency Requirements

Core Rotations

Inpatient Hematology / Oncology

  • Adult Leukemia
  • Lymphoma
  • Non-Malignant Hematology
  • Stem Cell Transplant and CAR-T Therapy (Off-site)

Ambulatory Hematology / Oncology Clinics

  • Breast
  • Central Nervous System
  • Gastrointestinal
  • Genitourinary
  • Gynecology
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Non-Malignant Hematology
  • Thoracic, Head & Neck
  • Sarcoma

Oncology Clinical Practice Operation

  • Chemotherapy Verification / Sterile Compounding

Investigational Drug Services (IDS)

  • Investigational BEACON Treatment Plan Review
  • Investigational Protocol Review


Residents may repeat any core rotation in which they have a particular interest in. Elective rotations may be selected from, but are not limited to:

  • Inpatient / Outpatient Non-Malignant Hematology
  • Ambulatory Oncology – Focus area of interest
  • Ambulatory Infusion center-based practice


  • Medication Safety
  • Formulary Management
  • Pharmacy Informatics
  • Financial Patient Assistance Process
  • Medication Use Evaluation


  • Major and Minor Research Projects
  • Continuing Education Presentation
  • Oncology Topic Discussions
  • Journal Club and Case Presentations
  • Nursing Inservices
  • Layered Teaching Learning Opportunities (PGY1 residents and APPE students)

Service Component

The resident will provide clinical oncology operations support which includes chemotherapy order entry and verification, as well as chemotherapy preparation and checking. The resident will be assigned to work 2 days per month which may include Thanksgiving or Christmas, and 1-2 minor holidays.

Frequently Asked Questions

What are the program's admission requirements?

Individuals wishing to apply to the Harris Health Residency Program must:

  • Be a graduate of an ACPE-­accredited College of Pharmacy
  • Have current valid pharmacy license in the state of Texas, or be eligible for licensure
  • Completion of a ASHP accredited Postgraduate Year One Residency Program
  • Enroll in the Residency Matching Program

Can Harris Health sponsor applicants with visas?

Harris Health cannot sponsor student work visas.

What is Harris Health System’s Oncology Postgraduate Year Two Program ASHP Accreditation Status?

The Postgraduate Year Two Oncology program conducted by Harris Health System in Houston, TX has a candidate accreditation status with ASHP. However, our world class oncology / hematology care preceptor team has provided guidance and stewardship in the specialized practice of oncology / hematology pharmacotherapy to ASHP accredited Postgraduate Year One Program and Postgraduate Year Two Administration program residents for 15 years.

What documents are required for program application?

Applications shall be deemed complete upon the receipt of the following:

  • Curriculum Vitae
  • Letter of Interest
    • Describe your reasons for pursuing a PGY2 Oncology residency. The letter should include details about your professional interests, achievements, and your five-year goals as a pharmacist.
  • Official Transcripts
    • Official transcripts related to pharmacy education are required
  • Three (3) Letters of Recommendation
    • Reference writers must complete the standardized reference form in the PhORCAS system.
    • One letter of recommendation must be from a pharmacist who has supervised you or an APPE preceptor.
  • Postgraduate Year One Pharmacy Residency certificate of completion.
  • What is the official start date of the program?

    The official start date of the program is July 1, 2024.

    When is the application deadline?

    All application materials must be submitted through Pharmacy Online Residency Centralized Application Service (PhORCAS) System by January 2 of every year. The National Matching Service Code is 670160 – PGY2 Oncology.

    How can I apply for this residency program?

    Application materials shall be submitted via the PhORCAS System.

    For additional information, please contact:

    Betty Chan, PharmD, BCOP
    Clinical Pharmacy Coordinator
    Oncology Services
    Residency Program Director
    Lauren Bailey, PharmD, BCOP
    Clinical Pharmacy Specialist
    Oncology Services
    Residency Program Coordinator